- US-listed companies
- Addex Therapeutics Ltd.
Addex Therapeutics Ltd.ADXN
Market cap
P/E ratio
Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
Cash and cash equivalents | 32 | 19 | 20 | 7 |
Other financial assets | 13,968 | 64,930 | 17,145 | 3,165 |
Trade and other receivables | 118,028 | 68,373 | 164,785 | 416,875 |
Contract asset | - | - | 159,636 | 181,441 |
Prepayments | 720,063 | - | - | 270,394 |
Total current assets | 32 | 19 | 22 | 8 |
Right-of-use assets | 543,340 | 565,344 | 469,989 | 357,613 |
Property, plant and equipment | 27,626 | 67,760 | 72,111 | 41,121 |
Non-current financial assets | 68,911 | 59,144 | 57,908 | 54,355 |
Total non-current assets | 639,877 | 692,248 | 600,008 | 453,089 |
Total assets | 33 | 20 | 23 | 8 |
Current lease liabilities | 373,025 | 308,611 | 287,698 | 286,107 |
Payables and accruals | 4 | 2 | 4 | 3 |
Total current liabilities | 6 | 4 | 4 | 3 |
Non-current lease liabilities | 177,220 | 258,785 | 194,316 | 87,028 |
Retirement benefits obligations | 1 | 2 | 1 | - |
Total non-current liabilities | 2 | 2 | 1 | 87,028 |
Share capital | 33 | 33 | 49 | 1 |
Share premium | 286 | 287 | 284 | 270 |
Other equity | - | - | - | 65 |
Treasury shares reserve | - | - | 12 | 6 |
Other reserves | - | - | 24 | 26 |
Retained earnings | -300,847,289 | -313,705,888 | -329,057,802 | -349,862,015 |
Total equity | 26 | 15 | 17 | 5 |
Total liabilities and equity | 33 | 20 | 23 | 8 |